Skip to main content

Spark signs gene therapy licensing deal valued at up to $328.5M

The agreement includes exclusive rights to an experimental gene therapy for epilepsy.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.